Global IVD Contract Manufacturing Market Size study & Forecast, by Device Type (IVD Equipment, IVD Consumables), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Others), by Service

Global IVD Contract Manufacturing Market Size study & Forecast, by Device Type (IVD Equipment, IVD Consumables), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Others), by Service Type (Manufacturing Services, Assay Development Services, Other Services), and Regional Analysis, 2023-2030

Global IVD Contract Manufacturing Market is valued at approximately USD 13.8 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 11.5% over the forecast period 2023-2030. IVD contract manufacturing refers to the outsourcing of manufacturing operations for in vitro diagnostic products to specialized contract manufacturers. These contract manufacturers provide a range of services, including product development, production, packaging, quality control, and regulatory compliance. By partnering with contract manufacturers, IVD companies can leverage their expertise, infrastructure, and manufacturing capabilities to streamline operations, reduce costs, ensure regulatory compliance, and meet the growing demand for diagnostic products. The IVD contract manufacturing market offers opportunities for innovation, geographic expansion, and strategic collaborations, while also facing challenges related to regulatory compliance, intellectual property protection, and supply chain management. The driving factors boosting the market growth are the growing IVD Market worldwide and increasing demand for IVD products.

The growing IVD (In Vitro Diagnostics) market is expected to have a positive impact on the IVD contract manufacturing market. As the demand for diagnostic tests and devices increases, IVD companies may seek the expertise and capabilities of contract manufacturers to meet the rising production needs. This surge in demand for contract manufacturing services is likely to drive the growth of the IVD contract manufacturing market, offering specialized manufacturing solutions to IVD companies and supporting the expansion of the overall IVD industry. According to Statista, the global market for in vitro diagnostics (IVD) was valued at around USD 91.2 billion in 2022. It is projected that by 2030, the IVD market is expected to exceed by USD 118 billion, with a compound annual growth rate (CAGR) of 3.2% between 2023 and 2030. In the medical technology industry, the in vitro diagnostics (IVD) segment held the largest share of revenue. In 2021, IVD accounted for more than 18%of the total global revenue in the medical technology industry. Moreover, the globalization of the IVD Market and increasing awareness in developing countries is expected to create abundant opportunities in the market. However, the lack of skilled workforce and high vulnerability to supply chain disruptions stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global IVD Contract Manufacturing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to factors such as well-established healthcare infrastructure, high healthcare expenditure, technological advancements, and the strong presence of key market players. Asia Pacific is expected to become the fastest growing during the forecast period, owing to factors such as increasing population, rising healthcare expenditure, expanding middle class, growing awareness about the benefits of early disease detection and personalized medicine.

Major market player included in this report are:
Jabil, Inc.
Thermo Fisher Scientific Inc.
West Pharmaceutical Services, Inc.
Charles River Laboratories International Inc.
Eurofins Scientific SE
Tecan Group Ltd.
Meridian Bioscience, Inc.
Celestica Inc.
Nipro Corporation
Sekisui Diagnostics LLC

Recent Developments in the Market:
In June 2023, Jabil Inc. launched its new high-performance server platform designed for time-sensitive, low-latency cloud and fintech applications. The Jabil J312-S 1U and JS322-S 2U servers are configured to order and powered by 4th Gen Intel® Xeon dual socket processors. These servers offer customizable options for high-speed, low-latency input/output (I/O), as well as hot-pluggable storage capabilities supporting NVMe, SAS, and SATA technologies. This launch is expected to have a significant impact on the IVD contract manufacturing market, as the advanced server platform equips contract manufacturers with the necessary technology to meet the growing demand for efficient and high-performance IVD solutions.
In May 2023, Thermo Fisher Scientific expanded its drug facility for vaccine manufacture in Singapore. This expansion is expected to have a positive impact on the IVD contract manufacturing market by creating opportunities for collaboration and partnership to support the manufacturing and distribution of vaccines, thus strengthening the overall healthcare industry.

Global IVD Contract Manufacturing Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Device Type, Technology, Service Type, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Device Type:
IVD Equipment
IVD Consumables

By Technology:
Immunoassay
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation & Hemostasis
Others
By Service Type:
Manufacturing Services
Assay Development Services
Other Services

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Jabil, Inc.
Thermo Fisher Scientific Inc.
West Pharmaceutical Services, Inc.
Charles River Laboratories International Inc.
Eurofins Scientific SE
Tecan Group Ltd.
Meridian Bioscience, Inc.
Celestica Inc.
Nipro Corporation
Sekisui Diagnostics LLC

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.